english.prescrire.org > Topics > Advancing healthcare policy > Advancing healthcare policy in Europe: a chronological recap of actions > 2018 Recap > Medicines shortages: drug companies have a duty to produce medicines in sufficient quantity and quality (5/2018)

Advancing healthcare policy

Advancing healthcare policy in Europe: a chronological recap of actions

A recap of actions in 2018
Medicines shortages: drug companies have a duty to produce medicines in sufficient quantity and quality (May 2018)

Paris, May 2018


Prescrire's response to a public consultation by the European Medicines Agency on non-compliance with good manufacturing practice (GMP) highlighted the growing problem with supplies of medicines of major therapeutic interest, in France and also in other European countries. Drug companies must be reminded that they have not just rights but also obligations, in particular the timely delivery of orders, while fully respecting GMP.
 

> Download Prescrire's response (pdf, 142 Ko)

©Prescrire May 2018

Share Share on Facebook Share on Twitter